A hexameric phosphorothioate oligonucleotide telomerase inhibitor arrests growth of Burkitt's lymphoma cells in vitro and in vivo

Toxicology and Applied Pharmacology
J E MataP Iversen

Abstract

A phosphorothioate oligonucleotide (PS-ODN) with sequence identical to the repeat sequence of the mammalian telomere, 5'-d(TTAGGG)-3', was incubated with a Burkitt's lymphoma-derived (OMA-BL1) cell line. This hexanucleotide inhibits telomerase activity in cell lysates, lengthens cell doubling time, and induces apoptosis. Concatenated repeats (12-, 18-, and 24-mers) of the 5'-d(TTAGGG)-3' motif induce similar cellular responses. Scrambled sequences do not efficiently inhibit telomerase activity or significantly alter cell growth and viability. The in vivo efficacy of this PS-ODN was evaluated in a xenograft human-nude mouse model. Once tumors were established these animals were administered the telomere mimic, 5'-d(TTAGGG)-3', a control scrambled sequence 5'-d(TGTGAG)-3', or saline for 14 days via a subcutaneous osmotic pumps in a blinded study monitoring tumor size with dose and time. A significant decrease in tumor size was observed in animals given 50 micrograms/mouse/day 5'-d(TTAGGG)-3', but not following 5'-d(TGTGAG)-3', relative to the saline-treated animals. The antitumor activity of the 6-mer telomere mimic demonstrated a dose dependency including a reduction in metastatic nodules in the spleen. No activity was observed ...Continue Reading

References

Dec 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·M Z RatajczakA M Gewirtz
Apr 25, 1991·Nature·A M ZahlerD M Prescott
Aug 3, 1995·Nature·M J McEachern, E H Blackburn
Feb 15, 1994·Proceedings of the National Academy of Sciences of the United States of America·J R WyattD J Ecker
Feb 1, 1996·Scientific American·C W Greider, E H Blackburn
Jan 1, 1996·Antisense & Nucleic Acid Drug Development·H W SharmaR Narayanan
Nov 1, 1995·Molecular Medicine Today·J W Shay
May 1, 1996·Nature Biotechnology·J C NortonD R Corey

❮ Previous
Next ❯

Citations

Jan 7, 2006·Oligonucleotides·Eckart MatthesMartin Von Janta-Lipinski
May 25, 2002·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·J FajkusJ Maláska
Feb 10, 2000·Annals of the New York Academy of Sciences·S P LichtsteinerA P Vasserot
Apr 21, 2001·Molecular and Cellular Biology·T MinaminoS Kourembanas
Apr 25, 2000·Annual Review of Medicine·V UrquidiS Goodison
Apr 23, 2014·Stem Cells and Development·Lida RadanDean Harvey Betts
Jul 5, 2005·Expert Opinion on Investigational Drugs·S SharmaD D Von Hoff
Jan 5, 2001·Expert Opinion on Investigational Drugs·P J Perry, T C Jenkins
Feb 7, 2001·Cancer Investigation·A J Davis, L L Siu
Feb 22, 2002·Cancer Investigation·Marco N HelderG J van der Zee
Dec 1, 2004·Veterinary and Comparative Oncology·D J ArgyleL Nasir
Nov 14, 1998·Annals of Medicine·V UrquidiS Goodison
Mar 6, 1999·The Journal of Biological Chemistry·W FuM P Mattson
Aug 5, 2000·Cancer·S A ElyD M Knowles
Jul 25, 2000·Antisense & Nucleic Acid Drug Development·R M HudziakP L Iversen
Jul 13, 2002·Expert Review of Anticancer Therapy·L Austin Doyle, W Edward Highsmith
Jan 16, 2007·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Tao XuFengjin Guo
Mar 27, 2001·International Journal of Cancer. Journal International Du Cancer·G B WismanA G van der Zee
Sep 28, 1998·Cancer Chemotherapy and Pharmacology·A L BoralB A Chabner
Oct 19, 2000·Anti-cancer Drugs·L R Kelland
Nov 28, 2002·Journal of Gastroenterology and Hepatology·Shi-Ming YangWei-Wen Liu
Jan 28, 2004·Cancer Research·Jan GrimmRalph Weissleder
Sep 30, 1999·Experimental Cell Research·T J PageP L Iversen
Dec 2, 1999·Journal of Hepatology·R Erlitzki, G Y Minuk
Aug 15, 2002·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·N ZaffaroniM G Daidone
Jun 14, 2003·Pharmacology & Therapeutics·Kathleen F PirolloEsther H Chang
Jul 12, 2003·Experimental Gerontology·Shuji KishiStephanie B Tsai
Feb 7, 1998·Journal of Pharmaceutical Sciences·R M BrandP L Iversen
Sep 24, 2013·Journal of Medicinal Chemistry·Vijay SekaranMichael B Jarstfer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.